LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today announced that CytRx President and CEO Steven A. Kriegsman and Vice President – Business Development David J. Haen will present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference on Tuesday, March 16, 2010 at 11:00 a.m. Pacific time (2:00 p.m. Eastern time). The conference is being held at the Ritz Carlton in Dana Point, California.
